Clinical Trials Directory

Trials / Unknown

UnknownNCT05607134

Effect of Extracorporeal Shock Wave and Peripheral Magnetic Stimulation on Spastic CP Children

Effect of Radial Extracorporeal Shock Wave and Peripheral Magnetic Stimulation on Upper Limb in Children With Spastic Hemiplegia

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
45 (estimated)
Sponsor
Cairo University · Academic / Other
Sex
All
Age
6 Years – 10 Years
Healthy volunteers
Not accepted

Summary

Hypotheses: There will be an effect of radial extracorporeal shock wave therapy and peripheral magnetic stimulation on the following parameters, in children with spastic hemiplegia: * Wrist flexors spasticity. * Wrist joint range of motion. * Hand grip muscles strength. * Sensorimotor function of wrist and hand.

Detailed description

Significance of the study: Reducing muscle hypertonia or spasticity in order to regain independent mobility is an essential goal of a physiotherapeutical treatment in neuro-rehabilitation. The rapid normalization of the muscle tone is a criterion that can crucially influence the outcome of future rehabilitation or in training programs. Purposes of the study: To evaluate the effect of radial extracorporeal shock wave therapy and peripheral magnetic stimulation on the following parameters, in Children with Spastic Hemiplegia: * Wrist flexors spasticity. * Wrist joint range of motion. * Hand grip muscles strength. * Sensorimotor function of wrist and hand. Methods: Forty-five children with hemiplegic cerebral palsy, aged from 6 to 10 years, will be enrolled in this study. Wrist flexors spasticity, Wrist joint range of motion, Hand grip muscles strength, Sensorimotor function of wrist and hand will be assessed. Data Analysis and statistical design: Normally distributed numerical data will be statistically described in terms of mean standard deviation, while not-normal data will be represented as median and range or inter-quartile range (IQR). Qualitative (categorical) data will be described in frequencies (number of cases) and percentage. Numerical data will be tested for the normal assumption using Kolmogorov Smirnov test. Comparison of numerical variables between the study groups will be done using One Way Analysis of variance (ANOVA) test when normally distributed and Kruskal Wallis analysis of variance (ANOVA) test when not normal. For comparing categorical data, Chi-square test will be performed. Exact test will be used instead when the expected frequency is less than 5. A probability value (p value) less than 0.05 is considered statistically significant. All statistical calculations will be done using computer programs Microsoft Excel 2019 (Microsoft Corporation, NY, USA) and IBM SPSS (Statistical Package for the Social Science; IBM Corp, Armonk, NY, USA) release 22 for Microsoft Windows.

Conditions

Interventions

TypeNameDescription
OTHERselected physical and occupational therapy programThe children in this group will receive a selected physical and occupational therapy programs one hour three times weekly for eight successive weeks.
DEVICERadial Extracorporeal Shock WaveThe children in this group will receive in addition to the selected physical therapy and occupational program as single session of shock wave intervention once per week for four eight successive weeks using (STORZ MEDICAL AG, Tagerwilen, Schweiz) device. rESWT will be applied on flexor carpi ulnaris, flexor carpi radialis, in the middle of the muscle belly and tendons of flexor digitorum on the palm. The treatment protocol of rESW will follow; 1500 shoots for each muscle; 0.030 mj/mm2; 4 HZ with pressure 1 bar will be used.
DEVICEPeripheral magnetic stimulationThe children in this group will receive in addition to the selected physical therapy program peripheral magnetic stimulation (PMS) therapy for twenty minutes, three sessions per week, for eight successive weeks using Peripheral magnetic stimulation device "A MAGNUM XL Pro, Globus, Italia". The PMS consisted of 2000 stimuli at a stimulation frequency of 20Hz, a train duration of 1 second, and an intertrain interval of 2 seconds. Intensity was individually set at 10% to 100% of the maximum stimulus intensity.

Timeline

Start date
2023-01-01
Primary completion
2023-12-01
Completion
2024-05-01
First posted
2022-11-07
Last updated
2023-02-08

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05607134. Inclusion in this directory is not an endorsement.